MARY DILORENZO: Open Payments
NPI 1437499506 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$26,209 in 46 payments from 7 companies in 2025. Trend: 2023 $25,264 · 2024 $14,591 · 2025 $26,209
Speaker / faculty: $14,652Travel & lodging: $6,857Consulting: $3,333Food & beverage: $1,368
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $8,780 |
| JAZZ PHARMACEUTICALS INC. | 16 | $8,435 |
| ABBVIE INC. | 5 | $3,623 |
| Genmab U.S., Inc. | 4 | $3,346 |
| Janssen Biotech, Inc. | 2 | $1,958 |
| Celgene Corporation | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
Products named: CALQUENCE, DEFITELIO, EPKINLY, DARZALEX, REBLOZYL, NINLARO.
Industry payments across NC — which companies pay providers there.
